• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于可视化抗原特异性T细胞的MHC-肽四聚体。

MHC-peptide tetramers to visualize antigen-specific T cells.

作者信息

Altman John D, Davis Mark M

机构信息

Emory University School of Medicine, Atlanta, Georgia.

Stanford University School of Medicine and The Howard Hughes Medical Institute, Palo Alto, California.

出版信息

Curr Protoc Immunol. 2003 May;Chapter 17:17.3.1-17.3.33. doi: 10.1002/0471142735.im1703s53.

DOI:10.1002/0471142735.im1703s53
PMID:18432902
Abstract

Mature T lymphocytes of the CD8 or CD4 classes bear alphabeta T cell receptors (TCR) that are specific for a molecular complex consisting of a major histocompatibility complex class I or II (MHC class I or II) molecule bound to a unique self or foreign peptide. Until recently, methods for monitoring the T cell immune response to a viral or tumor antigen were restricted primarily to functional assays based on limiting dilution analysis, because the lack of specific molecular reagents to identify clonal T cells obviated approaches to identify and enumerate specific T cells. Development of efficient methods to express and refold MHC class I molecules with synthetic peptides coincided with identification of specific protein sequences that provide the substrate for enzymatic biotinylation. This combination has led to the development of a straightforward method for generating synthetic TCR ligands, making them tetravalent to provide increased avidity, and labeling them through a streptavidin moiety with useful fluorescent tags such as fluorescein or phycoerythrin. This unit describes the preparation of MHC class I/peptide tetramers in detail, including bacterial expression and refolding of the MHC class I light chain, beta2-microglobulin (beta2m), as well as the formation of a complex consisting of the MHC class I heavy chain of interest, beta2m, and a chosen peptide.

摘要

CD8或CD4类成熟T淋巴细胞携带αβ T细胞受体(TCR),这些受体对由与独特的自身或外来肽结合的主要组织相容性复合体I类或II类(MHC I类或II类)分子组成的分子复合物具有特异性。直到最近,监测T细胞对病毒或肿瘤抗原免疫反应的方法主要限于基于有限稀释分析的功能测定,因为缺乏鉴定克隆性T细胞的特异性分子试剂,排除了鉴定和计数特定T细胞的方法。用合成肽表达和重折叠MHC I类分子的有效方法的发展与鉴定为酶促生物素化提供底物的特定蛋白质序列同时发生。这种结合导致了一种直接方法的发展,用于生成合成TCR配体,使其具有四价以提高亲和力,并通过链霉亲和素部分用诸如荧光素或藻红蛋白等有用的荧光标签进行标记。本单元详细描述了MHC I类/肽四聚体的制备,包括MHC I类轻链β2-微球蛋白(β2m)的细菌表达和重折叠,以及由感兴趣的MHC I类重链、β2m和选定肽组成的复合物的形成。

相似文献

1
MHC-peptide tetramers to visualize antigen-specific T cells.用于可视化抗原特异性T细胞的MHC-肽四聚体。
Curr Protoc Immunol. 2003 May;Chapter 17:17.3.1-17.3.33. doi: 10.1002/0471142735.im1703s53.
2
MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.用于可视化抗原特异性T细胞的MHC-肽四聚体
Curr Protoc Immunol. 2016 Nov 1;115:17.3.1-17.3.44. doi: 10.1002/cpim.14.
3
[MHC tetramers: tracking specific immunity].[MHC四聚体:追踪特异性免疫]
Acta Med Croatica. 2003;57(4):255-9.
4
Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.HLA II类四聚体在追踪抗原特异性T细胞及绘制T细胞表位图谱中的应用。
Methods. 2003 Mar;29(3):282-8. doi: 10.1016/s1046-2023(02)00350-x.
5
One-pot, mix-and-read peptide-MHC tetramers.一步法、混合即读型肽-MHC四聚体
PLoS One. 2008 Feb 27;3(2):e1678. doi: 10.1371/journal.pone.0001678.
6
MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.MHC II类四聚体与抗原特异性T细胞的探寻:定义、偏离、清除
Clin Immunol. 2004 Mar;110(3):232-42. doi: 10.1016/j.clim.2003.11.004.
7
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.构建嵌合的人源和鼠源主要组织相容性复合体(MHC)I类四聚体以生产T细胞受体(TCR)模拟抗体。
PLoS One. 2017 Apr 27;12(4):e0176642. doi: 10.1371/journal.pone.0176642. eCollection 2017.
8
Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.用毒素偶联肽-MHC Ⅰ类四聚体删除识别次要组织相容性抗原 HY 的幼稚 T 细胞可抑制同源 CTL 反应并改变免疫优势。
Transpl Immunol. 2013 Dec;29(1-4):138-45. doi: 10.1016/j.trim.2013.10.005. Epub 2013 Oct 23.
9
Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.逃避阴性选择且缺乏调节活性的自身特异性MHC II类限制性CD4-CD8-T细胞。
J Immunol. 2003 Jan 1;170(1):201-9. doi: 10.4049/jimmunol.170.1.201.
10
Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle.使用“一锅法、混合和读取”肽-MHC Ⅰ类四聚体和预测算法提高牛细胞毒性 T 淋巴细胞反应的检测。
Vet Res. 2014 Apr 28;45(1):50. doi: 10.1186/1297-9716-45-50.

引用本文的文献

1
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.针对 HLA 受限新抗原的嵌合抗原受体的结构工程。
Nat Commun. 2021 Sep 6;12(1):5271. doi: 10.1038/s41467-021-25605-4.
2
Allosteric activation of T cell antigen receptor signaling by quaternary structure relaxation.通过四级结构松弛实现T细胞抗原受体信号的变构激活。
Cell Rep. 2021 Jul 13;36(2):109375. doi: 10.1016/j.celrep.2021.109375.
3
MHC multimer: A Molecular Toolbox for Immunologists.MHC 多聚体:免疫学家的分子工具盒。
Mol Cells. 2021 May 31;44(5):328-334. doi: 10.14348/molcells.2021.0052.
4
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.在人类非小细胞肺癌中进行共享 T 细胞特异性的全局分析,可实现 HLA 推断和抗原发现。
Immunity. 2021 Mar 9;54(3):586-602.e8. doi: 10.1016/j.immuni.2021.02.014.
5
ApoB-Specific CD4 T Cells in Mouse and Human Atherosclerosis.载脂蛋白 B 特异性 CD4 T 细胞在鼠和人动脉粥样硬化中的作用。
Cells. 2021 Feb 19;10(2):446. doi: 10.3390/cells10020446.
6
Discordance Between the Predicted Versus the Actually Recognized CD8+ T Cell Epitopes of HCMV pp65 Antigen and Aleatory Epitope Dominance.巨细胞病毒 pp65 抗原的预测与实际识别的 CD8+ T 细胞表位之间的差异与偶然表位优势。
Front Immunol. 2021 Feb 9;11:618428. doi: 10.3389/fimmu.2020.618428. eCollection 2020.
7
Epitope prediction and identification- adaptive T cell responses in humans.表位预测和鉴定——人类适应性 T 细胞反应。
Semin Immunol. 2020 Aug;50:101418. doi: 10.1016/j.smim.2020.101418. Epub 2020 Oct 31.
8
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.具有治疗潜力的 HLA 限制性和人巨细胞病毒特异性抗体库的鉴定。
Cancer Immunol Immunother. 2020 Aug;69(8):1535-1548. doi: 10.1007/s00262-020-02564-1. Epub 2020 Apr 16.
9
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.一种通过主要组织相容性复合体 I 新抗原呈递靶向突变 β-连环蛋白的工程化抗体片段。
J Biol Chem. 2019 Dec 13;294(50):19322-19334. doi: 10.1074/jbc.RA119.010251. Epub 2019 Nov 5.
10
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.靶向 LMP2A 的 TCR-模拟双特异性抗体对 EBV 恶性肿瘤显示出强大的活性。
JCI Insight. 2018 Feb 22;3(4). doi: 10.1172/jci.insight.97805.